Alnylam gets surprise FDA rejection for rare disease drug – Boston Business Journal – The Business Journals

1. Alnylam gets surprise FDA rejection for rare disease drug – Boston Business Journal The Business Journals
2. Alnylam abandons Onpattro expansion in US as FDA spurns rare heart disease bid FiercePharma
3. FDA rejects Alnylam’s request to expand approval of one of its drugs to include heart patients The Boston Globe
4. Alnylam gives up on expanded use of heart-disease drug in US after FDA declines approval Yahoo News
5. Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis Business Wire

Read original article here